공간 전사체학 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 워크플로우별, 샘플 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Spatial Transcriptomics Market Summary

The global spatial transcriptomics market size was estimated at USD 385.7 million in 2024 and is projected to reach USD 1.31 billion by 2033, growing at a CAGR of 14.69% from 2025 to 2033. The market growth is driven by the rising prevalence of genetic diseases, increased R&D in spatial OMICS, and advancements in sequencing technologies. A key driver is the use of genome spatial organization as a novel biomarker, since chromosome and gene positioning changes in diseases like cancer, enabling early diagnosis.

Technological advancements

The market for spatial transcriptomics has grown dramatically because of technological developments. More precise and detailed analysis of gene expression within the spatial context of tissues is now feasible due to advancements in high-throughput sequencing, sophisticated bioinformatics tools, and advanced imaging techniques. These advancements have made spatial transcriptomics experiments less time-consuming, expensive, and technically complex, increasing the technology's accessibility for academic institutions, pharmaceutical firms, and clinical labs.

Moreover, these technological developments have enabled researchers to uncover complex biological insights that were previously unattainable. By providing detailed maps of gene expression in specific tissue locations, spatial transcriptomics facilitates the identification of novel biomarkers and therapeutic targets, particularly in areas like cancer and neurodegenerative diseases. As a result, the enhanced capabilities and growing efficiency of spatial transcriptomics technologies continue to drive demand across the genomics and precision medicine landscape.

Emerging Potential of Spatial Omics Analysis as a Cancer Diagnostic Tool

The market is expanding significantly due to the growing potential of spatial omics analysis as a cancer diagnostic tool. By examining the spatial arrangement of genes, proteins, and other biomolecules within tissues, spatial omics allows researchers to gain a thorough understanding of tumor microenvironments and the course of disease. This method offers the possibility of earlier and more precise cancer detection by identifying disease-specific patterns and molecular signatures that conventional bulk analyses are unable to detect.

In addition, spatial omics makes it easier to find new biomarkers that can be used as prognostic and predictive markers in cancer diagnostics. Researchers can differentiate between healthy and diseased tissue with previously unheard-of precision by mapping the exact location and interaction of genes and cellular components. This capacity increases the clinical relevance and uptake of spatial omics technologies by facilitating the creation of tailored treatment plans and targeted therapies. As a result, one of the main factors driving market demand is its use in oncology.

Global Spatial Transcriptomics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global spatial transcriptomics market based on product, technology, workflow, sample type, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
  • By Mode
  • Automated
  • Semi-automated
  • Manual
  • By Type
  • Sequencing Platforms
  • IHC
  • Microscopy
  • Flow Cytometry
  • Mass Spectrometry
  • Others
• Consumables
• Software
  • Bioinformatics Tools
  • Imaging Tools
  • Storage and Management Databases
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Sequencing-based Methods
  • Laser Capture Microdissection (LCM)
  • Transcriptome In-Vivo Analysis (TIVA)
  • In Situ Sequencing
  • Microtomy Sequencing
• IHC
• Microscopy-based RNA Imaging Techniques
  • Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
  • Padlock Probes/ Rolling Circle Amplification
  • Branched DNA Probes
• Workflow Outlook (Revenue, USD Million, 2021 - 2033)
• Sample Preparation
• Instrumental Analysis
• Data Analysis
• Sample Type Outlook (Revenue, USD Million, 2021 - 2033)
• FFPE
• Fresh Frozen
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Translational Research
• Academic Customers
• Diagnostic Customers
• Pharmaceutical Manufacturer
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Technology
  • 1.2.3. Workflow
  • 1.2.4. Sample Type
  • 1.2.5. End-use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological advancements in transcriptomics
    • 3.2.1.2. Emerging potential of spatial omic analysis as a cancer diagnostic tool
    • 3.2.1.3. Advent of fourth generation of sequencing (in situ sequencing)
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of instruments
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Spatial Transcriptomics Market: Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Spatial Transcriptomics Market Product Movement Analysis
• 4.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Instrument
  • 4.4.1. Global Instrument Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. By Mode
    • 4.4.2.1. Automated
      • 4.4.2.1.1. Global Automated Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. Semi-automated
      • 4.4.2.2.1. Global Semi-automated Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.3. Manual
      • 4.4.2.3.1. Global Manual Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. By Type
    • 4.4.3.1. Sequencing Platforms
      • 4.4.3.1.1. Global Sequencing Platforms Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. IHC
      • 4.4.3.2.1. Global IHC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.3. Microscopy
      • 4.4.3.3.1. Global Microscopy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.4. Flow Cytometry
      • 4.4.3.4.1. Global Flow Cytometry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.5. Mass Spectrometry
      • 4.4.3.5.1. Global Mass Spectrometry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.6. Others
      • 4.4.3.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Consumables
  • 4.5.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Software
  • 4.6.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. Bioinformatics Tools
    • 4.6.2.1. Global Bioinformatics Tools Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.3. Imaging Tools
    • 4.6.3.1. Global Imaging Tools Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.4. Storage and Management Databases
    • 4.6.4.1. Global Storage and Management Databases Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Spatial Transcriptomics Market: Technology Business Analysis

• 5.1. Technology Segment Dashboard
• 5.2. Global Spatial Transcriptomics Market Technology, Movement Analysis
• 5.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 5.4. Sequencing-based Methods
  • 5.4.1. Global Sequencing-based Methods Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Laser Capture Microdissection (LCM)
    • 5.4.2.1. Global Laser Capture Microdissection (LCM) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Transcriptome In-Vivo Analysis (TIVA)
    • 5.4.3.1. Global Transcriptome In-Vivo Analysis (TIVA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. In Situ Sequencing
    • 5.4.4.1. Global In Situ Sequencing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.5. Microtomy Sequencing
    • 5.4.5.1. Global Microtomy Sequencing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. IHC
  • 5.5.1. Global IHC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Microscopy-based RNA Imaging Techniques
  • 5.6.1. Global Microscopy-based RNA Imaging Techniques Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
    • 5.6.2.1. Global Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. Padlock Probes/ Rolling Circle Amplification
    • 5.6.3.1. Global Padlock Probes/ Rolling Circle Amplification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.4. Branched DNA Probes
    • 5.6.4.1. Global Branched DNA Probes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Spatial Transcriptomics Market: Workflow Business Analysis

• 6.1. Workflow Segment Dashboard
• 6.2. Global Spatial Transcriptomics Market Workflow Movement Analysis
• 6.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
• 6.4. Sample Preparation
  • 6.4.1. Global Sample Preparation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Instrumental Analysis
  • 6.5.1. Global Instrumental Analysis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Data Analysis
  • 6.6.1. Global Data Analysis Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Spatial Transcriptomics Market: Sample Type Business Analysis

• 7.1. Sample Type Segment Dashboard
• 7.2. Global Spatial Transcriptomics Market Sample Type Movement Analysis
• 7.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Sample Type, 2021 to 2033 (USD Million)
• 7.4. FFPE
  • 7.4.1. Global FFPE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Fresh Frozen
  • 7.5.1. Global Fresh Frozen Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Spatial Transcriptomics Market: End Use Business Analysis

• 8.1. End Use Segment Dashboard
• 8.2. Global Spatial Transcriptomics Market End Use Movement Analysis
• 8.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Translational Research
  • 8.4.1. Global Translational Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Academic Customers
  • 8.5.1. Global Academic Customers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Diagnostic Customers
  • 8.6.1. Global Diagnostic Customers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Pharmaceutical Manufacturer
  • 8.7.1. Global Pharmaceutical Manufacturer Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Spatial Transcriptomics Market: Regional Estimates & Trend Analysis by Product, Technology, Workflow, Sample Type, & End Use

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. North America Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Australia Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. Thailand Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. South Korea Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. Saudi Arabia Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. UAE Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Spatial Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2024
• 10.4. Participant's Overview
  • 10.4.1. Illumina, Inc.
    • 10.4.1.1. Overview
    • 10.4.1.2. Financial Performance
    • 10.4.1.3. Product Benchmarking
    • 10.4.1.4. Strategic Initiatives
  • 10.4.2. NanoString Technologies, Inc.
    • 10.4.2.1. Overview
    • 10.4.2.2. Financial Performance
    • 10.4.2.3. Product Benchmarking
    • 10.4.2.4. Strategic Initiatives
  • 10.4.3. 10x Genomics.
    • 10.4.3.1. Overview
    • 10.4.3.2. Financial Performance
    • 10.4.3.3. Product Benchmarking
    • 10.4.3.4. Strategic Initiatives
  • 10.4.4. Cantata Bio
    • 10.4.4.1. Overview
    • 10.4.4.2. Financial Performance
    • 10.4.4.3. Product Benchmarking
    • 10.4.4.4. Strategic Initiatives
  • 10.4.5. Bruker
    • 10.4.5.1. Overview
    • 10.4.5.2. Financial Performance
    • 10.4.5.3. Product Benchmarking
    • 10.4.5.4. Strategic Initiatives
  • 10.4.6. EVOSEP
    • 10.4.6.1. Overview
    • 10.4.6.2. Financial Performance
    • 10.4.6.3. Product Benchmarking
    • 10.4.6.4. Strategic Initiatives
  • 10.4.7. Shimadzu Corporation
    • 10.4.7.1. Overview
    • 10.4.7.2. Financial Performance
    • 10.4.7.3. Product Benchmarking
    • 10.4.7.4. Strategic Initiatives
  • 10.4.8. Waters
    • 10.4.8.1. Overview
    • 10.4.8.2. Financial Performance
    • 10.4.8.3. Product Benchmarking
    • 10.4.8.4. Strategic Initiatives
  • 10.4.9. Horizon Discovery Group plc
    • 10.4.9.1. Overview
    • 10.4.9.2. Financial Performance
    • 10.4.9.3. Product Benchmarking
    • 10.4.9.4. Strategic Initiatives
  • 10.4.10. Bio-Techne
    • 10.4.10.1. Overview
    • 10.4.10.2. Financial Performance
    • 10.4.10.3. Product Benchmarking
    • 10.4.10.4. Strategic Initiatives